Govx stock forecast 2025 investor risk profiles show GOVX stock

Investor risk profiles show GOVX stock forecast 2025 may align with a moderate-growth scenario, assuming cash burn rate stabilizes under $10 million annually through product monetization. Sep 26, 2025 · According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for GeoVax Labs is $8.50, with a high forecast of $9.00 and a low forecast of $8.00. Investors remember firms like Moderna NASDAQ: MRNA , whose shares appreciated over 500% from the beginning of the COVID-19 pandemic to the end of 2022. So, it’s not surprising that companies developing Mpox treatments are seeing massive spikes in share price. However, some key differences raise concerns over whether GeoVax can sustain similar returns. Institutional momentum in biotech ETFs may influence GOVX stock forecast 2025, with ETF net inflows potentially lifting the stock by 8–12% in bullish scenarios tied to health research breakthroughs.